PD Dr. med.

Lisa

Weibel

2016: Venia legendi (Habilitation), Universität Zürich, «Innovative Aspekte der lokalisierte Sklerodermie (Morphea) im Kindesalter»
2005-2007: Research Fellowship in Pediatric Dermatology, Department of Pediatric Dermatology, Great Ormond Street Hospital for Children, London, UK (Prof. John Harper, Dr. David Atherton)
2001: Promotion, Universität Zürich, «HIV-positive drug-addicts in programs of maintenance treatment with heroine», Supervision Prof. Dr. med. et PH F. Gutzwiller, Institut für Sozial- und Präventivmedizin

2009-2011: Oberärztin Pädiatrische Dermatologie, Dermatologische Klinik, UniversitätsSpital Zürich (Prof. Dr. med. L. French) und Universitäts-Kinderspital Zürich (Prof. Dr. med. F.H. Sennhauser)
2007-2009: Assistenzärztin Dermatologie, Dermatologische Klinik, UniversitätsSpital Zürich (Prof. Dr. med. L. French)
2005-2007: Fellow in Pediatric Dermatology Department, Great Ormond Street Hospital for Children, London, UK (Prof. John Harper)
2003-2005: Assistenzärztin Pädiatrie, Universitäts-Kinderspital Zürich (Prof. Dr. med. F.H. Sennhauser)
2002-2003: Assistenzärztin Pädiatrie, Klinik für Kinder- und Jugendliche, Stadtspital Triemli, (Dr. med. U. Bühlmann)
2001-2002: Assistenzärztin Kinderchirurgie und Pädiatrie (Neonatologie und Intensivstation), Kinderklinik Luzern, (Prof. Dr. med. M.G. Schwöbel and Prof. Dr. med. Th. Berger)

Zertifikate Good Clinical Practice (Module 1-3), Clinical Trial Center Zurich, zuletzt 2019
2018: «Wirksam führen in komplexen Situationen», Interprofesionelles Führungsseminar für Kader, Universitäts-Kinderspital Zürich
2010: Basiskurs Didaktik, Universität Zürich
Teilnahme an zahlreichen nationalen und internationalen Fortbildungen/Kongressen

• 2020: Poster Preis, Swiss Society for Dermatology and Venereology (SGDV) 
• 2020: Best Poster Price, category Cancer/Birthmarks/Genetics/neonatal, Society for Pediatric Dermatology (SGP) Meeting
• 2019: Prize for best poster («Secukinumab therapy for netherton syndrome») by the Swiss Society for Dermatology and Venerology (SGDV)
• 2018: Prize for best poster («Safe and effective use of alitretinoin in children with recalcitrant hand eczema and other dermatoses») by the Swiss Society for Dermatology and Venerology (SGDV)
• 2017: Prize «Dermatologe aus ganzem Herzen», Swiss Society for Dermatology and Venerology (SGDV), sponsored by La Roche Posay/L’Oreal
• 2016: Prize for best poster («Using negative pressure wound treatment in a neonate with epidermolysis bullosa») by the European Society for Pediatric Dermatology (ESPD), Paris
• 2012: Prize for best oral presentation («Topical betablockers are effective for the treatment of infantile hemangioma but systemically absorbed») from the European Society for Pediatric Dermatology (ESPD), Istanbul
• 2011: Poster Prize for the best clinical study («Topical betablockers are effective for the treatment of infantile hemangioma but systemically absorbed») at the Annual Congress of the Swiss Society for Dermatology (SGDV)
• 2008: Ruggero Caputo Young Pediatric Dermatologist Prize of the European Society for Pediatric Dermatology (ESPD), Athens, for the publication «Laser Doppler flowmetry for assessing localized scleroderma in children» Arthr Rheum 2007
• 2007: Prize for best oral presentation («Prenatal onset of localized scleroderma causing facial hemiatrophy and hemiplegia») at the Annual Meeting of the British Society of Paediatric Dermatology (BSPD), London

• European Hemangioma Task Force, Swiss Representative
• Editorial Board Member of «Pediatric Dermatology», Wiley Periodical Inc.
• Working Group Member for the European Teaching Program in Pediatric Dermatology, European Society of Pediatrics (ESPD)
• Europen Reference Network – Skin (ERN-Skin)
• Swiss Group for Vascular Anomalies in Children (SGVAC), President
• Zürcher Tuberous Sclerosis Complex (TSC) Platform, Board Member
• Medical Advisor für Sanofi-Genzyme, El-Lilly, Novartis, Pfizer, Merz, Pierre Fabre, L’Oreal

• Swiss Group for Pediatric Dermatology (SGPD), Board Member
• Schweizerische Gesellschaft für Dermatologie und Venerologie (SGDV)
• European Society for Pediatric Dermatology (ESPD), Board Member
• International Society for the Study of Vascular Anomalies (ISSVA)
• Arbeitsgemeinschaft Pädiatrische Dermatologie (AGPD)
• Zürcher Dermatologische Gesellschaft (ZDG)
• FMH
• VSAO

• Lokalisierte Sklerodermie (Morphea)
• Vaskuläre Tumoren und Malformationen 
• Genetische Hauterkrankungen/rare diseases (u. a. Netherton Syndrom)
• Mosaik-Erkrankungen der Haut

• 2014: radiz – Rare Disease Initiative Zurich, Research grant for an investigator-initiated clinical research trial «Investigation of the genetic architecture of linear localized scleroderma (LLS) by whole exome sequencing»
• 2010: «Protected Time», University of Zurich, research grant
• 2010: Research Donation for Pediatric Dermatology by Prof. R.M. Trüeb
• 2009: Nachwuchsförderungskommission der Universität Zürich (Stiefel-Zangger Stiftung), research grant
• 2009: Donation UBS AG by order of a client, Universitäts-Kinderspital Zürich, research grant
• 2009: Spirig Pharma AG. Educational and Research grant of 2’500 Sfr
• 2007: The Eagle Foundation, University of Geneva, Switzerland. Educational and Research grant
• 2006: Spirig Pharma AG. Educational and Research grant
• 2006: Nachwuchsförderungskommission der Universität Zürich (Stiefel-Zangger Stiftung). Research grant
• 2005: Theodor und Ida Herzog-Egli-Stiftung. Educational and Research Grant
• 2005: Novartis Stiftung, previously Ciba-Geigy-Jubiläums-Stiftung. Educational and Research grant

• ORCID